Julie Tisserand

Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab

Adrien Costantini, Catherine Julié, Coraline Duménil et al. · OncoImmunology · 2018 · 173 citations · Full text

Medicine, Immunology, Oncology +17

Frequencies of KIT and PDGFRA mutations in the MolecGIST prospective population-based study differ from those of advanced GISTs

J.-F. Emile, S. Brahimi, Jean‐Michel Coindre et al. · Medical Oncology · 2011 · 122 citations

Medicine, Genetics, Molecular Genetics +13

Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab

Julia Ouaknine Krief, Pierre Helly de Tauriers, Coraline Duménil et al. · Journal for ImmunoTherapy of Cancer · 2019 · 97 citations · Full text

Life Sciences, Immunology, Oncology +16

Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer

Etienne Giroux‐Leprieur, Guillaume Herbretau, Coraline Duménil et al. · OncoImmunology · 2018 · 84 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Daniela Matuozzo, Estelle Talouarn, Astrid Marchal et al. · Genome Medicine · 2023 · 77 citations · Full text

Life Sciences, Genetics, Immunology +17